TrialFrontiers in immunology2026

Humoral immune response to polyvalent pneumococcal vaccine in healthy participants receiving efgartigimod: a randomized, open-label, placebo-controlled, parallel-group phase 1 trial.

Antoine E Azar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.